These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16088365)

  • 21. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.
    Llabre MM; Weaver KE; Durán RE; Antoni MH; McPherson-Baker S; Schneiderman N
    AIDS Patient Care STDS; 2006 Oct; 20(10):701-11. PubMed ID: 17052140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of treatment complexity on adherence and incidence of blips in HIV/HCV coinfected patients.
    Calvo-Cidoncha E; González-Bueno J; Almeida-González CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2015 Feb; 21(2):153-7. PubMed ID: 25615004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
    Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP;
    Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.
    Tegegne AS; Ndlovu P; Zewotir T
    BMC Infect Dis; 2018 Feb; 18(1):83. PubMed ID: 29458343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure.
    Van Vaerenbergh K; De Geest S; Derdelinckx I; Bobbaers H; Carbonez A; Deschamps A; De Graeve V; De Saar V; Ceunen H; De Smet K; Maes B; Peetermans W; Schrooten Y; Desmyter J; De Clercq E; Van Ranst M; Van Wijngaerden E; Vandamme AM
    Antivir Chem Chemother; 2002 Jul; 13(4):231-40. PubMed ID: 12495211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients.
    Fong OW; Ho CF; Fung LY; Lee FK; Tse WH; Yuen CY; Sin KP; Wong KH
    HIV Med; 2003 Apr; 4(2):133-8. PubMed ID: 12702134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Rueda S; Park-Wyllie LY; Bayoumi AM; Tynan AM; Antoniou TA; Rourke SB; Glazier RH
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD001442. PubMed ID: 16855968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions to improve adherence to antiretroviral therapy.
    Tuldrà A; Wu AW
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S154-7. PubMed ID: 12562041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.
    de Bruin M; Viechtbauer W; Schaalma HP; Kok G; Abraham C; Hospers HJ
    Arch Intern Med; 2010 Feb; 170(3):240-50. PubMed ID: 20142568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active?
    Visnegarwala F; Graviss EA; Sajja P; Lahart CJ; White AC
    HIV Clin Trials; 2004; 5(3):117-24. PubMed ID: 15248135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence assessment to highly active antiretroviral therapy.
    Tsasis P
    AIDS Patient Care STDS; 2001 Mar; 15(3):109-15. PubMed ID: 11313023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to HAART among patients with HIV: breakthroughs and barriers.
    Ickovics JR; Meade CS
    AIDS Care; 2002 Jun; 14(3):309-18. PubMed ID: 12042076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A qualitative study of persons who are 100% adherent to antiretroviral therapy.
    Lewis MP; Colbert A; Erlen J; Meyers M
    AIDS Care; 2006 Feb; 18(2):140-8. PubMed ID: 16338772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electronic monitoring: adherence assessment or intervention?
    Wagner GJ; Ghosh-Dastidar B
    HIV Clin Trials; 2002; 3(1):45-51. PubMed ID: 11819185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence.
    Witteveen E; van Ameijden EJ
    Subst Use Misuse; 2002; 37(14):1905-25. PubMed ID: 12511058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to antiretroviral therapy in pregnancy.
    Kingston MA; Letham CJ; McQuillan O
    Int J STD AIDS; 2007 Nov; 18(11):787-9. PubMed ID: 18005515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.